J Veen

1.6k total citations
63 papers, 1.3k citations indexed

About

J Veen is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, J Veen has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 29 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in J Veen's work include Tuberculosis Research and Epidemiology (31 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Mycobacterium research and diagnosis (10 papers). J Veen is often cited by papers focused on Tuberculosis Research and Epidemiology (31 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers) and Mycobacterium research and diagnosis (10 papers). J Veen collaborates with scholars based in Netherlands, France and Malawi. J Veen's co-authors include Martien W. Borgdorff, Dick van Soolingen, T. E. W. Feltkamp, Mario Raviǵlione, Nico Kalisvaart, Nico Nagelkerke, H. L. Rieder, Giovanni Battista Migliori, N. J. D. Nagelkerke and Jan D. A. van Embden and has published in prestigious journals such as The Lancet, American Journal of Epidemiology and Annals of the New York Academy of Sciences.

In The Last Decade

J Veen

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Veen Netherlands 19 950 763 398 126 81 63 1.3k
Alan B. Bloch United States 15 1.2k 1.3× 1.0k 1.3× 647 1.6× 72 0.6× 122 1.5× 25 1.8k
Pasakorn Akarasewi Thailand 24 978 1.0× 958 1.3× 243 0.6× 154 1.2× 74 0.9× 43 1.6k
Diana Antoniskis United States 14 1.1k 1.1× 964 1.3× 351 0.9× 290 2.3× 67 0.8× 20 1.6k
Taraz Samandari United States 22 1.1k 1.1× 919 1.2× 254 0.6× 125 1.0× 87 1.1× 46 1.4k
Jos Bogaerts Rwanda 15 430 0.5× 488 0.6× 178 0.4× 180 1.4× 89 1.1× 16 1.1k
Joseph H. Perriëns Switzerland 18 935 1.0× 658 0.9× 126 0.3× 252 2.0× 48 0.6× 30 1.2k
Kari Brattegaard United States 18 961 1.0× 738 1.0× 187 0.5× 367 2.9× 77 1.0× 22 1.3k
Kisali Pallangyo Tanzania 22 955 1.0× 712 0.9× 321 0.8× 171 1.4× 205 2.5× 65 1.6k
Carol Holm‐Hansen Norway 20 778 0.8× 507 0.7× 200 0.5× 241 1.9× 82 1.0× 41 1000
Victor Mudenda Zambia 21 691 0.7× 913 1.2× 362 0.9× 109 0.9× 41 0.5× 53 1.7k

Countries citing papers authored by J Veen

Since Specialization
Citations

This map shows the geographic impact of J Veen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Veen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Veen more than expected).

Fields of papers citing papers by J Veen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Veen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Veen. The network helps show where J Veen may publish in the future.

Co-authorship network of co-authors of J Veen

This figure shows the co-authorship network connecting the top 25 collaborators of J Veen. A scholar is included among the top collaborators of J Veen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Veen. J Veen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Vassall, Anna, et al.. (2008). Reforming tuberculosis control in Ukraine: results of pilot projects and implications for the national scale-up of DOTS. Health Policy and Planning. 24(1). 55–62. 15 indexed citations
3.
Salaniponi, F M, et al.. (2004). Risk of infection with Mycobacterium tuberculosis in Malawi: national tuberculin survey 1994.. PubMed. 8(6). 718–23. 15 indexed citations
4.
Borgdorff, Martien W., J Veen, Nico Kalisvaart, J. F. Broekmans, & Nico Nagelkerke. (2000). Defaulting from tuberculosis treatment in the Netherlands: rates, risk factors and trend in the period 1993–1997. European Respiratory Journal. 16(2). 209–209. 34 indexed citations
5.
Jong, J J de, Jaap Goudsmit, Vladimir V. Lukashov, et al.. (1999). Insertion of two animo acids combined with changes in reverse transcriptase containing tyrosine-215 of HIV-1 resistant to multiple nucleoside analogs. AIDS. 13(1). 75–80. 95 indexed citations
6.
Antoine, D, V Schwoebel, J Veen, Mario Raviǵlione, & Hans L. Rieder. (1998). Surveillance de la tuberculose dans la Région Europe de l'OMS, 1995-1996. Eurosurveillance. 3(11). 103–107.
8.
Jansen, Henning, et al.. (1998). Nationwide surveillance of drug-resistant tuberculosis in The Netherlands: rates, risk factors and treatment outcome.. PubMed. 2(4). 288–95. 34 indexed citations
9.
Kiers, Albert, et al.. (1996). [Border-crossing source tracing in tuberculosis via DNA fingerprint technique].. PubMed. 140(46). 2290–3. 3 indexed citations
10.
Weezenbeek, C.S.B. Lambregts-van & J Veen. (1995). Control of drug-resistant tuberculosis. Tubercle and Lung Disease. 76(5). 455–459. 30 indexed citations
11.
Zaaijer, Hans L., J Veen, H. W. Reesink, et al.. (1995). Detection of HIV-1 RNA in plasma by isothermal amplification (NASBA) irrespective of the stage of HIV-1 infection. Journal of Virological Methods. 52(1-2). 175–181. 13 indexed citations
12.
Zaaijer, Hans L., Eveline P. Mauser‐Bunschoten, J Veen, et al.. (1995). Hepatitis E virus antibodies among patients with hemophilia, blood donors, and hepatitis patients. Journal of Medical Virology. 46(3). 244–246. 27 indexed citations
13.
Zaaijer, Hans L., et al.. (1994). Detection of HIV‐1 DNA in Leukocytes Using a Commercially Available Assay. Vox Sanguinis. 66(1). 78–80. 6 indexed citations
14.
Veen, J. (1992). Microepidemics of tuberculosis: the stone-in-the-pond principle. Tubercle and Lung Disease. 73(2). 73–76. 125 indexed citations
15.
Veen, J. (1991). Tuberculosis in a low prevalence country: A wolf in sheep's clothing.. PubMed. 66(4). 203–5. 7 indexed citations
16.
Veen, J, et al.. (1989). [Tuberculosis, a continuing challenge].. PubMed. 133(2). 61–5. 1 indexed citations
17.
Veen, J. (1987). [BCG vaccination for travelers to tropical regions?].. PubMed. 131(19). 811–2. 1 indexed citations
18.
Berge, R.J.M. ten, P.Th.A. Schellekens, S. Surachno, et al.. (1981). The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients. Clinical Immunology and Immunopathology. 21(1). 20–32. 25 indexed citations
19.
Liem, Koen L., et al.. (1979). Incidence and Significance of Heartmuscle Antibodies in Patients with Acute Myocardial Infarction and Unstable Angina. Acta Medica Scandinavica. 206(1-6). 473–475. 21 indexed citations
20.
Veen, J, et al.. (1967). Homotypic and heterotypic antibody response in infants to adenovirus vaccine. Archives of Virology. 21(3-4). 320–333. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026